Skip to main content
All lobbying filings

Cavarocchi Ruscio Dennis Associates, L.L.C.

Cavarocchi Ruscio Dennis Associates, L.L.C. filed a Q1 report for Pancreatic Cancer Action Network (Pancan) on April 15, 2026, reporting $30,000 in lobbying income.

Lobbying for Pancreatic Cancer Action Network (Pancan)

As filed: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for PANCREATIC CANCER ACTION NETWORK (PANCAN).

All filings by Cavarocchi Ruscio Dennis Associates, L.L.C. · Everything Pancreatic Cancer Action Network (Pancan) has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 15, 2026
Income
$30,000
What the client paid this registrant for the period.

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

H.R. 7148, FY 2026 Consolidated Appropriations Act, Pancreatic Cancer Research Program and NIH research on pancreatic cancer;H.R/S. Unnumbered, FY 2027 Defense Appropriations Act, Pancreatic Cancer Research Program; H.R./S. Unnumbered, FY 2027 Labor-Health and Human Services-Education Appropriations Act, NIH research on pancreatic cancer

H.R. 7148, FY 2026 Consolidated Appropriations Act, Pancreatic Cancer Research Program and NIH research on pancreatic cancer;H.R./S. Unnumbered, FY 2027 Defense Appropriations Act, Pancreatic Cancer Research Program; H.R./S. Unnumbered FY 2027 Labor-Health and Human Services-Education Appropriations Act, NIH research on pancreatic cancer

H.R. 7148, FY 2026 Consolidated Appropriations Act, Pancreatic Cancer Research Program; H.R./S. Unnumbered, FY 2027 Defense Appropriations Act, Pancreatic Cancer Research Program

 Bills named in this filing 1
  • H.R. 7148
    Consolidated Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem